CHAPTER 7 — ACETYLCHOLINE

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/34

encourage image

There's no tags or description

Looks like no tags are added yet.

35 Terms

1
New cards

Acetylcholine — Neurotransmitter used in the CNS, autonomic nervous system, and neuromuscular junction.

2
New cards

Choline — Precursor used to synthesize acetylcholine.

3
New cards

Acetyl-CoA — Molecule that combines with choline to produce acetylcholine.

4
New cards

Choline acetyltransferase — Enzyme that synthesizes acetylcholine from choline and acetyl-CoA.

5
New cards

ACh synthesis — Choline + acetyl-CoA → acetylcholine, catalyzed by choline acetyltransferase.

6
New cards

ACh storage — Acetylcholine is packaged into synaptic vesicles before release.

7
New cards

ACh release — Acetylcholine is released from synaptic vesicles into the synaptic space.

8
New cards

Acetylcholinesterase — Enzyme that rapidly breaks down acetylcholine and terminates its signal.

9
New cards

AChE inhibition — Prevents rapid breakdown of acetylcholine, increasing and prolonging cholinergic signaling.

10
New cards

Nicotinic receptor — Ionotropic acetylcholine receptor that directly controls an ion channel and produces fast effects.

11
New cards

Muscarinic receptor — Metabotropic acetylcholine receptor that acts through G proteins and second messengers.

12
New cards

Nicotinic versus muscarinic receptors — Nicotinic receptors are ionotropic and fast; muscarinic receptors are metabotropic and slower and modulatory.

13
New cards

Nicotinic receptor desensitization — Prolonged exposure to an agonist can cause nicotinic receptors to enter a desensitized state in which they respond less effectively.

14
New cards

Desensitized nicotinic receptor — Receptor state in which the receptor responds less effectively to an agonist after prolonged exposure.

15
New cards

Resensitization — Return of a desensitized nicotinic receptor to a responsive state.

16
New cards

Muscarinic receptors — Five major types of muscarinic receptors are M1 through M5.

17
New cards

M5 receptor — Muscarinic receptor found in areas including the hippocampus, hypothalamus, and midbrain dopamine regions; may contribute to drug reward and dependence.

18
New cards

Basal forebrain cholinergic system — Acetylcholine system projecting broadly to the cortex and hippocampus and involved in attention, learning, and memory.

19
New cards

ACh and cognition — Acetylcholine contributes to attention, learning, memory, and cortical activation.

20
New cards

Alzheimer's disease and acetylcholine — Loss of cholinergic function contributes to cognitive impairment in Alzheimer's disease.

21
New cards

AChE inhibitors and Alzheimer's — AChE inhibitors increase acetylcholine signaling and can provide limited symptomatic cognitive benefits.

22
New cards

Autonomic ganglia — Primarily use nicotinic acetylcholine receptors.

23
New cards

Parasympathetic targets — Primarily use muscarinic acetylcholine receptors.

24
New cards

Neuromuscular junction — Site where motor neurons communicate with skeletal muscle using nicotinic acetylcholine receptors.

25
New cards

Cholinergic blockade at the neuromuscular junction — Blocking acetylcholine release or receptors at the neuromuscular junction can produce weakness or paralysis.

26
New cards

M3 receptor — Muscarinic receptor involved in glandular secretion and insulin release.

27
New cards

M3 and insulin — Acetylcholine activation of M3 receptors on pancreatic beta cells stimulates insulin secretion.

28
New cards

M3 and salivation and lacrimation — M3 activation contributes to salivation and tear production.

29
New cards

Muscarinic antagonist — Drug that blocks muscarinic receptors and reduces parasympathetic signaling.

30
New cards

Atropine — Muscarinic antagonist that blocks acetylcholine's effects at muscarinic receptors.

31
New cards

Scopolamine — Muscarinic antagonist that blocks muscarinic acetylcholine receptors.

32
New cards

Antimuscarinic effects — Blocking muscarinic signaling can produce effects such as dry mouth by reducing parasympathetic secretion.

33
New cards

Blood-brain barrier and cholinergic drugs — Whether a drug crosses the blood-brain barrier helps determine whether it produces central effects, peripheral effects, or both.

34
New cards

Central acetylcholine — Acetylcholine signaling in the CNS involved in attention, learning, and memory.

35
New cards

Peripheral acetylcholine — Acetylcholine signaling involved in autonomic functions and communication at the neuromuscular junction.